Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1990-08-01
1992-08-04
Chan, Nicky
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514554, 514651, 549443, 562585, 564352, A61K 3136, A61K 31205, C07D31758, C07C21720
Patent
active
051359472
ABSTRACT:
The present invention provides 1-phenyl-3-naphthalenyloxypropanamines which are selective inhibitors of serotonin uptake.
REFERENCES:
patent: 4018895 (1977-04-01), Molloy et al.
patent: 4194009 (1980-03-01), Molloy et al.
patent: 4207343 (1980-05-01), Lavagnino et al.
patent: 4314081 (1982-02-01), Molloy et al.
patent: 4329356 (1982-05-01), Holland
Cronenberger et al., Chemie Therapeutique, 5/6, 289 (1966).
Robertson David W.
Thompson Dennis C.
Wong David T.
Chan Nicky
Conrad Robert A.
Eli Lilly and Company
Whitaker Leroy
LandOfFree
1-phenyl-3-naphthalenyloxypropanamines and their use as selectiv does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 1-phenyl-3-naphthalenyloxypropanamines and their use as selectiv, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 1-phenyl-3-naphthalenyloxypropanamines and their use as selectiv will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-778564